Originally, the molecular diagnostics of squamous cell carcinoma (SCC) was based on the absence of certain targetable genomic alterations that are commonly found in adenocarcinoma—i.e., EGFR and ALK [59]. This evidence concerns the gene EGFR and squamous cell carcinoma.